Atypical hemolytic uremic syndrome
- Atypical hemolytic-uremic syndrome
- Atypical HUS
- Hemolytic-uremic syndrome without diarrhea
- GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.
The Rare Thrombotic Diseases Consortium aims to improve the lives of people with antiphospholipid antibody syndromes, heparin-induced thrombocytopenia, paroxysmal nocturnal hemoglobinuria, catastrophic antiphospholipid antibody syndrome (thrombotic storm), and thrombotic thrombocytopenic purpura (TTP) through research.
For more information, please contact:
Hemostasis and Thrombosis Research Center
Duke University Health System
P.O. Box 3422 DUMC
315 Trent Dr. Rm 273
Durham, NC 27710
(Alexion Pharmaceuticals, Inc.)
The FDA has approved this product to be used in this manner.
|For the treatment of atypical Hemolytic Uremic Syndrome (aHUS)|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information